AAV-miR-ATXN2

N/A

Report date: 2024/04/23 11:59:21

Base Information

Drug NameAAV-miR-ATXN2
Drug Alias NameAAV-miR-ATXN2
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionAtaxin-2 expression inhibitors
TargetsAtaxin-2
Therapy Area/IndicationsAmyotrophic Lateral SclerosisFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAviadoBio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAviadoBio Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisFrontotemporal Dementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A